Global Blood Screening Market Analysis, 2020

By Solutions (Reagents & Kits [Nucleic Acid Technology (NAT) (Enzymes & Polymerases, Standards & Controls, Probes & Primers, Buffers, Nucleotides, And Solutions, Labeling & Detection Reagents), Elisa (Immunosorbents, Controls, Conjugates, Substrates, Sample Diluents & Wash Solutions), Instruments (Rental Purchase, Outright Purchase), Software & Services]), By Technology (Nucleic Acid Testing (Transcription-Mediated Amplification, Real-Time Polymerase Chain Reaction), Enzyme-Linked Immunosorbent Assay (Chemiluminescence Immunoassay, Fluorescent Immunoassay, Colorimetric Immunoassays), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)), By End-User (Blood Banks, Hospital), By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa), By Country (US, Canada, Mexico, Brazil, UK, Germany, France, Italy, Spain, China, Japan, India, Australia, UAE, Saudi Arabia, South Africa)

  • Healthcare
  • Jul 2020
  • 208
  • HC22031